1. Home
  2. SONN vs RHE Comparison

SONN vs RHE Comparison

Compare SONN & RHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • RHE
  • Stock Information
  • Founded
  • SONN N/A
  • RHE 1988
  • Country
  • SONN United States
  • RHE United States
  • Employees
  • SONN N/A
  • RHE N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • RHE Real Estate
  • Sector
  • SONN Health Care
  • RHE Real Estate
  • Exchange
  • SONN Nasdaq
  • RHE Nasdaq
  • Market Cap
  • SONN 3.3M
  • RHE 3.5M
  • IPO Year
  • SONN N/A
  • RHE 2006
  • Fundamental
  • Price
  • SONN $2.98
  • RHE $1.51
  • Analyst Decision
  • SONN Strong Buy
  • RHE
  • Analyst Count
  • SONN 3
  • RHE 0
  • Target Price
  • SONN $117.33
  • RHE N/A
  • AVG Volume (30 Days)
  • SONN 1.4M
  • RHE 32.2K
  • Earning Date
  • SONN 12-12-2024
  • RHE 11-19-2024
  • Dividend Yield
  • SONN N/A
  • RHE N/A
  • EPS Growth
  • SONN N/A
  • RHE N/A
  • EPS
  • SONN N/A
  • RHE N/A
  • Revenue
  • SONN $55,881.00
  • RHE $15,753,000.00
  • Revenue This Year
  • SONN N/A
  • RHE N/A
  • Revenue Next Year
  • SONN N/A
  • RHE N/A
  • P/E Ratio
  • SONN N/A
  • RHE N/A
  • Revenue Growth
  • SONN N/A
  • RHE N/A
  • 52 Week Low
  • SONN $2.50
  • RHE $1.13
  • 52 Week High
  • SONN $18.72
  • RHE $3.08
  • Technical
  • Relative Strength Index (RSI)
  • SONN 30.17
  • RHE 42.96
  • Support Level
  • SONN $2.50
  • RHE $1.13
  • Resistance Level
  • SONN $3.50
  • RHE $1.71
  • Average True Range (ATR)
  • SONN 0.85
  • RHE 0.21
  • MACD
  • SONN 0.00
  • RHE -0.02
  • Stochastic Oscillator
  • SONN 6.38
  • RHE 38.78

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About RHE Regional Health Properties Inc.

Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.

Share on Social Networks: